Yahoo
ASX - Delayed Quote AUD

Ramsay Health Care Limited (RHC.AX)

55.60 +0.68 (+1.24%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for RHC.AX
  • Previous Close 54.92
  • Open 55.40
  • Bid 55.06 x --
  • Ask 55.60 x --
  • Day's Range 55.01 - 55.90
  • 52 Week Range 30.39 - 56.10
  • Volume 632,912
  • Avg. Volume 875,584
  • Market Cap (intraday) 12.834B
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) 40.88
  • EPS (TTM) 1.36
  • Earnings Date Aug 27, 2026
  • Forward Dividend & Yield 0.97 (1.74%)
  • Ex-Dividend Date Sep 3, 2026
  • 1y Target Est 52.11

Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.

www.ramsayhealth.com

91,400

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

RHC.AX
64.90%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

RHC.AX
76.51%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

RHC.AX
21.21%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

RHC.AX
13.91%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY23
Revenue 3.96B
Earnings 137M
Profit Margin 3.46%

Q3

FY22

Q4

FY22

Q2

FY23

0
1B
2B
3B
0.0%
1.0%
2.0%
3.0%

Analyst Insights

View More

Analyst Price Targets

41.90 Low
52.11 Average
55.60 Current
66.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.77%

  • Return on Assets (ttm)

    3.18%

  • Return on Equity (ttm)

    5.69%

  • Revenue (ttm)

    18.65B

  • Net Income Avi to Common (ttm)

    313.5M

  • Diluted EPS (ttm)

    1.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    730.4M

  • Total Debt/Equity (mrq)

    196.67%

  • Levered Free Cash Flow (ttm)

    706.17M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: